SRI and cancer: This review will explore the following: (i) sorcin’s structure and activation, (ii) sorcin’s cellular functions, (iii) sorcin overexpression in tumors and cancer cells, and its functions as an oncoprotein, (iv) the molecular mechanisms underlying sorcin’s role in multidrug resistance (MDR), and (v) the approaches aiming at targeting sorcin.